|
|
| (9 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| − | {{Bio
| + | #REDIRECT [[AltUser:Guglielmo_Roma]] |
| − | |Name=Guglielmo
| + | |
| − | |Surnames=Roma
| + | |
| − | |Photo=Guglielmo Roma.jpg
| + | |
| − | |Email_address=guglielmo.roma@crg.es
| + | |
| − | |Phone=+34 93 316 01 81
| + | |
| − | |HomePage=[http://es.linkedin.com/in/guglielmoroma LinkedIn]
| + | |
| − | }}
| + | |
| − | Guglielmo holds nine years of experience in bioinformatics in both Academic ([http://www.ceinge.unina.it/ CEINGE], [http://www.tigem.it/ TIGEM], currently [http://www.crg.cat/ CRG]) and Pharmaceutical environments ([http://www.merckserono.com/en/index.html MerckSerono International]). He obtained a master degree in Biology (University of Naples 1996-2001), a post-lauream Master in Bioinformatics (University of Benevento, 2002-2003) and a post-lauream Specialization in Clinical Biochemistry (Second University of Naples, 2001-2006). He is particularly interested into -omics sciences and, as bioinformatician, has contributed to several research projects (e.g. the discovery of novel transcripts expressed in ES cells [http://www.ncbi.nlm.nih.gov/pubmed/17540781], the development of biological resources and databases [http://www.ncbi.nlm.nih.gov/pubmed/19906694][http://www.ncbi.nlm.nih.gov/pubmed/17942430], the identification of disease genes using comparative genomics approaches [http://www.ncbi.nlm.nih.gov/pubmed/16174644] [http://sulfabase.tigem.it/], the discovery of gene regulatory networks). In MerckSerono, he was involved in the identification of clinical biomarkers (Phase Ia and Ib) through omics- data analysis approaches, and provided ad-hoc bioinformatics support to internal projects. He currently leads the CRG Bioinformatics Core Facility with the main goal to provide scientists, at CRG/PRBB and external institutions, with computational and data analysis expertise.
| + | |
| − | | + | |
| − | Guglielmo Roma may be contacted at +34 933160181 or by e-mail at the address mailto:guglielmo.roma@crg.es.
| + | |
